AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinstraesser, L.
Right arrow Articles by Wang, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinstraesser, L.
Right arrow Articles by Wang, S. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2002, p. 1837-1844, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1837-1844.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Activity of Novispirin G10 against Pseudomonas aeruginosa In Vitro and in Infected Burns

Lars Steinstraesser,1,2* Brian F. Tack,3 Alan J. Waring,4 Teresa Hong,4 Lee M. Boo,4 Ming-Hui Fan,1 Daniel I. Remick,5 Grace L. Su,6 Robert I. Lehrer,4 and Stewart C. Wang1

Departments of Surgery,1 Medicine,6 Pathology, University of Michigan, Ann Arbor, Michigan,5 Department of Microbiology, University of Iowa, Ames, Iowa,3 Department of Medicine, UCLA School of Medicine, Los Angeles, California,4 Department of Plastic and Reconstructive Surgery, Ruhr University Bergmannsheil, Bochum, Germany2

Received 13 April 2001/ Returned for modification 11 June 2001/ Accepted 7 March 2002

The emergence of multidrug-resistant microbes has serious implications for managing infection and sepsis and has stimulated efforts to develop alternative treatments, such as antimicrobial peptides. The objective of this study was to test a designer peptide, novispirin G10, against multidrug-resistant microorganisms. By two-stage radial diffusion assays, its activity against such organisms compared favorably with that of standard antibiotics and other antimicrobial peptides. It killed bacteria very rapidly, was nonhemolytic, and was relatively noncytotoxic. The peptide induced an immediate, massive efflux of potassium from Pseudomonas aeruginosa, suggesting that it altered the permeability of its inner membrane. The presence of human serum reduced but did not eliminate its activity. We tested the in vivo activity of novispirin G10 in rats with an infected, partial-thickness burn that covered 20% of their total body surface area. The burned area was seeded with 106 CFU of a Silvadene-resistant P. aeruginosa strain, and 24 h later a single treatment with 0, 1, 3, or 6 mg of synthetic novispirin G10 (n = 16 at each concentration) per kg was given intradermally. Significant bacterial killing (P < 0.0001) was evident within 4 h in each peptide group compared to controls receiving vehicle. Antimicrobial peptides such as novispirin G10 may provide a useful alternative or adjunct to standard antibiotic agents in treating burns or other wound infections.


* Corresponding author. Mailing address: Plastic and Reconstructive Surgery, Ruhr University Bergmannsheil, Buerkle-de-la-Camp Platz 1, 44789 Bochum, Germany. Phone: 49 (0234) 302-6841. Fax: 49 (0234) 302-6379. E-mail: lars.steinstraesser{at}ruhr-uni-bochum.de.


Antimicrobial Agents and Chemotherapy, June 2002, p. 1837-1844, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1837-1844.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.